During the past decade, Zhongshan Ophthalmic Center conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 3 clinical trials were completed, i.e. on average, 4.5% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 3 clinical trials were completed. i.e. 8.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zhongshan Ophthalmic Center" #1 sponsor was "Sun Yat-sen University" with 47 trials, followed by "Zhongshan Ophthalmic Center, Sun Yat-sen University" with 17 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Chengdu Kanghong Biotech Co., Ltd." with 2 trials sponsored and "Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zhongshan Ophthalmic Center" #1 collaborator was "Chinese Academy of Sciences" with 2 trials as a collaborator, "Chugai Pharmaceutical" with 2 trials as a collaborator, "The Second Affiliated Hospital of Harbin Medical University" with 2 trials as a collaborator, "Zhongshan Ophthalmic Center, Sun Yat-sen University" with 2 trials as a collaborator and "Asociación para Evitar la Ceguera en México" with 1 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Zhongshan Ophthalmic Center" are "Myopia" (8 trials), "Cataract" (7 trials), "Dry Eye" (4 trials), "Glaucoma" (4 trials) and "Macular Edema" (4 trials). Many other conditions were trialed in "Zhongshan Ophthalmic Center" in a lesser frequency.

Most popular intervention types in "Zhongshan Ophthalmic Center" are "Drug" (31 trials), "Procedure" (22 trials), "Other" (10 trials), "Diagnostic Test" (8 trials) and "Behavioral" (5 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (4 trials), "Faricimab" (4 trials), "Sham Procedure" (4 trials), "Placebo" (3 trials) and "Doxycycline" (2 trials). Other intervention names were less common.

The vast majority of trials in "Zhongshan Ophthalmic Center" are 80 trials for "All" genders.

Currently, there are NaN active trials in "Zhongshan Ophthalmic Center". 1 are not yet recruiting, 20 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Zhongshan Ophthalmic Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Zhongshan Ophthalmic Center, 6 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 36 trials that are defined as “Not Applicable".

Zhongshan Ophthalmic Center has several departments that took part in Clinical trials: "State Key Laboratory of Ophthalmology,Zhongshan Ophthalmic Center, Sun Yat-sen University" - 4 trials